innoscripta SE, a German provider of R&D management software, is significantly expanding its presence in Austria. The company announced today that a dedicated team, established this year to focus on the Austrian R&D tax credit, has already acquired more than 30 Austrian companies as customers and built an order backlog of more than EUR 1 million from concrete customer projects. This move underscores the growing importance of the Austrian market for innoscripta, which has had an office in Vienna since 2021, though it previously served primarily as a talent hub for its German operations.
The Austrian R&D tax credit, in place since 2002, offers a 14% tax credit on qualifying research and development expenditure. In 2024, Austrian companies applied for a total funding volume of EUR 1.4 billion, a figure that surpasses the approximately EUR 1.2 billion paid out under Germany's R&D tax allowance in 2025. This comparison highlights the significance of the Austrian market relative to its size, and innoscripta's early success there positions it to capitalize on this substantial funding pool.
“Our rapid market success in Austria is further evidence of the competitiveness of our software-centric approach with the innovative Clusterix platform,” said Sebastian Schwertlein, COO of innoscripta SE. “We are particularly pleased to have attracted a broad range of new customers across different sectors, including industry and manufacturing, software and IT, logistics, and retail. This demonstrates that our approach works across industries.”
The company's expansion into Austria is part of a broader international growth strategy, following market entries in France, the United Kingdom, and the United States. With Austria, innoscripta continues to extend its reach, offering its Clusterix platform to help companies manage their R&D activities efficiently.
Clusterix is a scalable software platform designed for the structured organization and management of research and development. It enables companies to manage innovation projects, digitize internal processes, and make R&D activities transparent and scalable. The platform's appeal is evident in the quick adoption by Austrian firms, which are leveraging the R&D tax credit to reduce their tax burden while enhancing their innovation capabilities.
The implications of innoscripta's expansion are significant for the Austrian market, as it brings a sophisticated digital tool to companies seeking to maximize their R&D tax benefits. For innoscripta, the strong order backlog signals robust demand and validates its business model in a market that has been established for 24 years. As the company continues to grow internationally, it is well-positioned to become a leading player in R&D management software across Europe and beyond.
